Evaluation of behavioral and social issues among Thai HIV vaccine trial volunteers

J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Mar 1;20(3):308-14. doi: 10.1097/00042560-199903010-00015.

Abstract

Behavioral and social issues were investigated in phase I/II preventive HIV vaccine trial volunteers in Thailand. These included risk behavior, HIV knowledge, distress, and social experiences associated with trial participation. Data were collected at baseline and at 4- and 8-month follow-up visits. Volunteers reported relatively low levels of risk behaviors at baseline and at the follow-up visits. About one fifth reported overtly negative reactions from family or friends. No problems with discrimination in employment, health care, or insurance were reported. Findings add to the evidence suggesting the feasibility of phase I/II prophylactic HIV vaccine trials with low-risk volunteers in Thailand.

Publication types

  • Clinical Trial
  • Clinical Trial, Phase I
  • Clinical Trial, Phase II
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • AIDS Vaccines*
  • Adult
  • Double-Blind Method
  • Evaluation Studies as Topic
  • Female
  • Follow-Up Studies
  • HIV Infections / prevention & control*
  • Health Knowledge, Attitudes, Practice
  • Humans
  • Life Style
  • Male
  • Middle Aged
  • Risk-Taking*
  • Thailand
  • Vaccines, Synthetic*
  • Volunteers / psychology*

Substances

  • AIDS Vaccines
  • Vaccines, Synthetic